Exogenous IL6 induces mRNA splice variant MBD2_v2 to promote stemness in TP53 wild-type, African American PCa cells.

about

Exogenous IL6 induces mRNA splice variant MBD2_v2 to promote stemness in TP53 wild-type, African American PCa cells.

Item

http://www.wikidata.org/entity/Q53684369

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Exogenous IL6 induces mRNA spl ...... e, African American PCa cells.

@en

Exogenous IL6 induces mRNA spl ...... e, African American PCa cells.

@nl

type

Item

label

Exogenous IL6 induces mRNA spl ...... e, African American PCa cells.

@en

Exogenous IL6 induces mRNA spl ...... e, African American PCa cells.

@nl

prefLabel

Exogenous IL6 induces mRNA spl ...... e, African American PCa cells.

@en

Exogenous IL6 induces mRNA spl ...... e, African American PCa cells.

@nl

P1476

Exogenous IL-6 induces mRNA sp ...... pe, African American PCa cells

@en

P2093

Bin Bao

http://www.w3.org/2001/XMLSchema#string

Christophe Legendre

http://www.w3.org/2001/XMLSchema#string

Cristina Mitrea

http://www.w3.org/2001/XMLSchema#string

Greg Dyson

http://www.w3.org/2001/XMLSchema#string

Isaac Powell

http://www.w3.org/2001/XMLSchema#string

John D Carpten

http://www.w3.org/2001/XMLSchema#string

Wael Sakr

http://www.w3.org/2001/XMLSchema#string

P2860

Gene expression profiling predicts clinical outcome of prostate cancer

Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks

TopHat: discovering splice junctions with RNA-Seq

Epidemiology, biology, and treatment of triple-negative breast cancer in women of African ancestry

ONCOMINE: a cancer microarray database and integrated data-mining platform

Prostate cancer stem cells: a new target for therapy

A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal

Socioeconomic status, healthcare density, and risk of prostate cancer among African American and Caucasian men in a large prospective study

Molecular alterations in primary prostate cancer after androgen ablation therapy.

Clinical and correlative results of SWOG S0354: a phase II trial of CNTO328 (siltuximab), a monoclonal antibody against interleukin-6, in chemotherapy-pretreated patients with castration-resistant prostate cancer

P304

1138-1152

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/1878-0261.12316

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Aliccia Bollig-Fischer

Emily A Teslow

P577

2018-05-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29741809

http://www.w3.org/2001/XMLSchema#string

P932

6026877

http://www.w3.org/2001/XMLSchema#string